| CD123 Redirected T Cells for AML in Pediatric Subjects (NCT04678336) | University of Pennsylvania | 2021-04-02 |
| Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients (NCT04836156) | Peking University People's Hospital | 2021-04-02 |
| A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC (NCT05223595) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2021-04-02 |
| A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men (NCT04802343) | Bayer | 2021-04-02 |
| FT516 and IL2 With Enoblituzumab for Ovarian Cancer (NCT04630769) | Masonic Cancer Center, University of Minnesota | 2021-04-02 |
| Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors (NCT05531708) | Shanghai Pudong Hospital | 2021-04-02 |
| Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT04761614) | Ning Jin | 2021-04-02 |
| Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation (NCT04088903) | Ronald Witteles | 2021-04-01 |
| A Study of Oral Ibogaine in Opioid Withdrawal (NCT05029401) | atai Therapeutics, Inc. | 2021-04-01 |
| MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis (NCT04815148) | Minghui Pharmaceutical Pty Ltd | 2021-04-01 |
| A Study of TG103 in Subjects With Type 2 Diabetes (NCT04790006) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-04-01 |
| Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia (NCT05342727) | The National Brain Mapping Laboratory (NBML) | 2021-04-01 |
| O2 Transport and Utilization in Health and Lung Disease (NCT04014712) | University of Massachusetts, Amherst | 2021-04-01 |
| A Study of Intranasal ChAdOx1 nCOV-19 (NCT04816019) | University of Oxford | 2021-04-01 |
| Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer (NCT04856371) | Haihe Biopharma Co., Ltd. | 2021-04-01 |
| The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 (NCT04840745) | Chong Kun Dang Pharmaceutical | 2021-04-01 |
| Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients (NCT04830878) | Stanford University | 2021-04-01 |
| The Adjunctive Use of Melatonin Therapy in the Treatment of Obese Periodontitis Patients (Clinical and Immunological Study). (NCT04788979) | University of Baghdad | 2021-04-01 |
| Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa (NCT04541550) | IntegoGen, LLC | 2021-04-01 |
| A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235 (NCT04464577) | Bristol-Myers Squibb | 2021-04-01 |
| Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder. (NCT05516407) | Fenix Innovation Group | 2021-04-01 |
| Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection (NCT05151614) | University of Baghdad | 2021-04-01 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic (NCT04927221) | Guangzhou JOYO Pharma Co., Ltd | 2021-04-01 |
| Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM) (NCT04686279) | University of Pennsylvania | 2021-04-01 |
| Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae (NCT05293873) | Vinmec Research Institute of Stem Cell and Gene Technology | 2021-04-01 |
| rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease (NCT04833907) | Myrtelle Inc. | 2021-04-01 |
| A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia (NCT04708236) | Oryn Therapeutics, LLC | 2021-04-01 |
| Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis (NCT04316442) | Sorrento Therapeutics, Inc. | 2021-04-01 |
| A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors (NCT04730843) | Elpiscience Biopharma, Ltd. | 2021-04-01 |
| Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy (NCT05009719) | St. Petersburg State Pavlov Medical University | 2021-04-01 |
| Transplantation of hAMSCs for Woman With DOR (NCT04706312) | The First Affiliated Hospital with Nanjing Medical University | 2021-04-01 |
| Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS (NCT04482712) | The University of Texas Health Science Center at San Antonio | 2021-04-01 |
| Liver Adiposity Effects on Pediatric Statin (NCT04903223) | Children's Mercy Hospital Kansas City | 2021-04-01 |
| Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors (NCT04764084) | Peking University Cancer Hospital & Institute | 2021-04-01 |
| Safety and Efficacy of the ElastiMed's SACS 2.0 - Smart Active Compression Stocking for the Treatment of Venous Edema (NCT04837560) | ElastiMed ltd | 2021-04-01 |
| Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease (NCT04808908) | University of Minnesota | 2021-04-01 |
| Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma (NCT04706936) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
| LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer (NCT04762901) | Wake Forest University Health Sciences | 2021-04-01 |
| Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function (NCT04823702) | NGM Biopharmaceuticals, Inc | 2021-04-01 |
| Bivalirudin vs Heparin in ECMO Patients (NCT03707418) | Johns Hopkins University | 2021-04-01 |
| A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043 (NCT04789304) | Boehringer Ingelheim | 2021-04-01 |
| Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer (NCT04597411) | Endocyte | 2021-04-01 |
| Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults (NCT04843631) | BioFactura Australia Pty Ltd. | 2021-04-01 |
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets (NCT04841720) | Haisco Pharmaceutical Group Co., Ltd. | 2021-04-01 |
| A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies (NCT04865458) | Sunshine Lake Pharma Co., Ltd. | 2021-04-01 |
| Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease (NCT04791878) | Anthony Lembo | 2021-04-01 |
| Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease (NCT05901818) | Xuanwu Hospital, Beijing | 2021-04-01 |
| This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors (NCT04762641) | ABL Bio, Inc. | 2021-04-01 |
| Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19 (NCT04738175) | Sorrento Therapeutics, Inc. | 2021-04-01 |
| Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects (NCT04818398) | Daiichi Sankyo Co., Ltd. | 2021-04-01 |
| Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy (NCT04599556) | Zhejiang University | 2021-04-01 |
| Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT05263271) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2021-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (NCT04418466) | Delpor, Inc. | 2021-04-01 |
| TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations (NCT04770246) | Taiho Oncology, Inc. | 2021-03-31 |
| Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies (NCT04828174) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2021-03-31 |
| Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520) | Pamela Munster | 2021-03-31 |
| Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers (NCT04729309) | Hoffmann-La Roche | 2021-03-31 |
| A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects (NCT04857047) | Boryung Pharmaceutical Co., Ltd | 2021-03-31 |
| Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL (NCT04796857) | Huiqiang Huang | 2021-03-31 |
| Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction (NCT03678467) | Epibone, Inc. | 2021-03-31 |
| Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults (NCT04785144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-03-31 |
| TL-895 and KRT-232 Study in Acute Myeloid Leukemia (NCT04669067) | Telios Pharma, Inc. | 2021-03-31 |
| A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food (NCT04811573) | Boehringer Ingelheim | 2021-03-31 |
| A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants (NCT04616677) | Janssen Research & Development, LLC | 2021-03-31 |
| A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device (NCT04832139) | Pfizer | 2021-03-30 |
| Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC) (NCT04614051) | Pharmicell Co., Ltd. | 2021-03-30 |
| Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects (NCT04788641) | AstraZeneca | 2021-03-30 |
| Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers (NCT04856969) | Autotelicbio | 2021-03-30 |
| Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer (NCT04840472) | Stanford University | 2021-03-30 |
| Pharmacodynamic Evaluation of Intranasal Nalmefene (NCT04828005) | Opiant Pharmaceuticals Inc | 2021-03-30 |
| Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA (NCT04798339) | H. Lee Moffitt Cancer Center and Research Institute | 2021-03-30 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma (NCT04718402) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-03-30 |
| Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT04810910) | Zhejiang Provincial People's Hospital | 2021-03-30 |
| A Study of SI-F019 in Healthy Participants (NCT04851444) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-03-30 |
| A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors (NCT04513223) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-30 |
| Study of PCUR-101 in Combination With ADT in Patients With mCRPC (NCT04677855) | Pellficure Pharmaceuticals, Inc | 2021-03-30 |
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma (NCT04831658) | Mingzhi Zhang | 2021-03-29 |
| A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers (NCT05136391) | Sinotau Pharmaceutical Group | 2021-03-29 |
| Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies (NCT04785287) | M.D. Anderson Cancer Center | 2021-03-29 |
| Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19 (NCT04824443) | Memorial Sloan Kettering Cancer Center | 2021-03-29 |
| BrUOG 390: Neoadjuvant Treatment With Talazoparib (NCT04598321) | Brown University | 2021-03-29 |
| Study of Codivir in Patients With COVID-19 (NCT04930861) | Code Pharma | 2021-03-29 |
| Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants (NCT04825223) | Sanofi Pasteur, a Sanofi Company | 2021-03-29 |
| TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients (NCT05434312) | Shenzhen TargetRx Co., Ltd. | 2021-03-29 |
| A Study of LY3502970 in Healthy Male Participants (NCT04680767) | Eli Lilly and Company | 2021-03-29 |
| A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients (NCT04811196) | University Health Network, Toronto | 2021-03-29 |
| To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment. (NCT04831944) | Incyte Corporation | 2021-03-29 |
| Recombinant Human Serum Albumin in Healthy Subjects (NCT05179265) | Protgen Ltd | 2021-03-29 |
| agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma (NCT04754100) | MiNK Therapeutics | 2021-03-29 |
| Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC (NCT05116007) | Akeso | 2021-03-29 |
| A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19 (NCT04809389) | The University of Hong Kong | 2021-03-29 |
| Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers (NCT04842682) | ANRS, Emerging Infectious Diseases | 2021-03-29 |
| A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years (NCT03962062) | Medicines Development for Global Health | 2021-03-29 |
| AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT04673617) | Artiva Biotherapeutics, Inc. | 2021-03-29 |
| Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor (NCT04800627) | M.D. Anderson Cancer Center | 2021-03-29 |
| CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) (NCT04684641) | Yale University | 2021-03-29 |
| Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI) (NCT04677829) | Pinteon Therapeutics, Inc | 2021-03-29 |
| A Single Dose Study to Evaluate the Pharmacokinetics of Acoramidis Modified Release Formulations in Healthy Subjects (NCT04769479) | Eidos Therapeutics, a BridgeBio company | 2021-03-28 |
| Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients (NCT04750122) | Peking University People's Hospital | 2021-03-28 |
| Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults (NCT04818281) | Ihsan GURSEL, PhD, Prof. | 2021-03-27 |